Showing 1 to 1 of 1 results
jpost.com
🌐 85% Global Worthiness
Varenicline Triples Adolescent Vaping Quit Rates in JAMA Study
A JAMA study shows varenicline, a drug for adult smoking cessation, triples adolescent (16-25) vaping quit rates (51% vs 14% placebo) after 12 weeks, with the success rate remaining higher three months later, highlighting a critical need for pharmacological interventions in tackling youth nicotine a...
Varenicline Triples Adolescent Vaping Quit Rates in JAMA Study
A JAMA study shows varenicline, a drug for adult smoking cessation, triples adolescent (16-25) vaping quit rates (51% vs 14% placebo) after 12 weeks, with the success rate remaining higher three months later, highlighting a critical need for pharmacological interventions in tackling youth nicotine a...
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results